» Articles » PMID: 1357243

20 Years or More of Follow-up of Living Kidney Donors

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1992 Oct 3
PMID 1357243
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

The perioperative and long-term risks for living kidney donors are of concern. We have studied donors at the University of Minnesota 20 years or more (mean 23.7) after donation by comparing renal function, blood pressure, and proteinuria in donors with siblings. In 57 donors (mean age 61 [SE 1]), mean serum creatinine is 1.1 (0.01) mg/dl, blood urea nitrogen 17 (0.5) mg/dl, creatinine clearance 82 (2) ml/min, and blood pressure 134 (2)/80 (1) mm Hg. 32% of the donors are taking antihypertensive drugs and 23% have proteinuria. The 65 siblings (mean age 58 [1.3]) do not significantly differ from the donors in any of these variables: 1.1 (0.03) mg/dl, 17 (1.2) mg/dl, 89 (3.3) ml/min, and 130 (3)/80 (1.5) mm Hg, respectively. 44% of the siblings are taking antihypertensives and 22% have proteinuria. To assess perioperative mortality, we surveyed all members of the American Society of Transplant Surgeons about donor mortality at their institutions. We documented 17 perioperative deaths in the USA and Canada after living donation, and estimate mortality to be 0.03%. We conclude that perioperative mortality in the USA and Canada after living-donor nephrectomy is low. In long-term follow-up of our living donors, we found no evidence of progressive renal deterioration or other serious disorders.

Citing Articles

Comprehensive Surgical Audit of Live-Related Donor Nephrectomy: Procedural Parameters, Demographics, Health Assessments, Complications, and Postoperative Outcomes.

Mahmood K, Ahmad A, Upadhyay R, Khatoon T, Imbisat Z, Akela A Cureus. 2024; 16(3):e57363.

PMID: 38694424 PMC: 11061546. DOI: 10.7759/cureus.57363.


Age and Pre-operative HbA1c levels affect renal function compensation in living kidney donors.

Ito T, Kenmochi T, Kurihara K, Aida N, Hasegawa M, Ishihara T Int Urol Nephrol. 2023; 56(4):1315-1322.

PMID: 38032440 DOI: 10.1007/s11255-023-03877-7.


The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controls.

Vock D, Helgeson E, Mullan A, Issa N, Sanka S, Saiki A BMC Nephrol. 2023; 24(1):121.

PMID: 37127560 PMC: 10152793. DOI: 10.1186/s12882-023-03149-7.


AKI3-Risk Predictors and Scores in Radical Nephrectomy with High Thrombectomy under Extracorporeal Circulation for Renal Cell Carcinoma with Supradiaphragmatic Inferior Vena Cava/Right Atrial Thrombus: A Single-Centre Retrospective Study.

Dragan A, Sinescu I Medicina (Kaunas). 2023; 59(2).

PMID: 36837587 PMC: 9962973. DOI: 10.3390/medicina59020386.


Investigating strategies to improve AccesS to Kidney transplantation (the ASK trial): a protocol for a feasibility randomised controlled trial with parallel process evaluation.

Bailey P, Caskey F, Macneill S, Ashford R, Pryce L, Kayler L Pilot Feasibility Stud. 2023; 9(1):13.

PMID: 36670510 PMC: 9854094. DOI: 10.1186/s40814-023-01241-1.